Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
|Articles|September 2, 2015
Susan Krigel Discusses Fear of Recurrence Among Cancer Survivors
Author(s)Susan Krigel
Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.
Advertisement
Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.
Advertisement
Related to this article
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer.
Dr. Dina Khalaf breaks down three clinical trials testing oral and targeted regimens for acute myeloid leukemia and myelodysplastic syndrome.
Advertisement
Advertisement
Trending on CURE
1
The Growing Role of AI in Cancer Care
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
3 More Lung Cancer Breakthroughs From WCLC 2026
4
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next
5